An open label extension shows additional benefit from a drug currently being tested for patients with Lou Gehrig’s disease.
Michigan Medicine is renowned for groundbreaking clinical, basic science and medical educational research, with nearly 7,000 papers published annually by faculty and trainees. Here, Lab Notes highlights a selection of those articles in addition to ones covered as stories on the Michigan Health Lab blog.
Percentage of all child health spending that went to orphan drugs rose 65% in five years, while families’ portion rose even faster.
Researchers explore the relationship between the Centers for Medicare and Medicaid Services financial incentives and hospital participation in a voluntary advanced alternative payment program.
A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.
Researchers report first clinically actionable findings for a rare blood vessel disease in a study of four unrelated families, all with the same genetic variant.